132 related articles for article (PubMed ID: 38296352)
1. Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
Maeda T; Matsuda A; Kanda J; Kawabata H; Ishikawa T; Tohyama K; Kitanaka A; Araseki K; Shimbo K; Hata T; Suzuki T; Kayano H; Usuki K; Shindo-Ueda M; Arima N; Nohgawa M; Ohta A; Chiba S; Miyazaki Y; Nakao S; Ozawa K; Arai S; Kurokawa M; Takaori-Kondo A; Mitani K;
Br J Haematol; 2024 May; 204(5):2086-2096. PubMed ID: 38296352
[TBL] [Abstract][Full Text] [Related]
2. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.
DeZern AE; Eapen M; Wu J; Talano JA; Solh M; Dávila Saldaña BJ; Karanes C; Horwitz ME; Mallhi K; Arai S; Farhadfar N; Hexner E; Westervelt P; Antin JH; Deeg HJ; Leifer E; Brodsky RA; Logan BR; Horowitz MM; Jones RJ; Pulsipher MA
Lancet Haematol; 2022 Sep; 9(9):e660-e669. PubMed ID: 35907408
[TBL] [Abstract][Full Text] [Related]
3. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
[TBL] [Abstract][Full Text] [Related]
4. Treatment of aplastic anaemia with lower-dose anti-thymocyte globulin produces similar response rates and survival as per standard dose anti-thymocyte globulin schedules.
Scott A; Morris K; Butler J; Mills AK; Kennedy GA
Intern Med J; 2016 Oct; 46(10):1198-1203. PubMed ID: 27404498
[TBL] [Abstract][Full Text] [Related]
5. Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome.
Bessho F; Ohnishi H; Tabuchi K; Kobayashi M; Hayashi Y
Br J Haematol; 1999 Apr; 105(1):149-54. PubMed ID: 10233378
[TBL] [Abstract][Full Text] [Related]
6. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.
Mahapatra M; Singh PK; Agarwal M; Prabhu M; Mishra P; Seth T; Tyagi S; Patil HP; Saxena R
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):30-5. PubMed ID: 26529865
[TBL] [Abstract][Full Text] [Related]
8. Deficient proliferation of myeloid, erythroid, and multipotent progenitor cells in long-term marrow cultures from patients with aplastic anemia treated with immunosuppressive therapy.
Gómez-Morales E; Martinez-Jaramillo G; Sánchez-Valle E; Valencia-Plata I; Arana-Trejo RM; Castro MA; Pizzuto-Chávez J; Mayani H
Am J Hematol; 1998 Oct; 59(2):149-55. PubMed ID: 9766800
[TBL] [Abstract][Full Text] [Related]
9. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
[TBL] [Abstract][Full Text] [Related]
12. Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia.
Lionel SA; Selvarajan S; Korula A; Kulkarni U; Devasia A; Abubacker FN; Abraham A; Mathews V; Lakshmi KM; George B
Indian J Hematol Blood Transfus; 2023 Jul; 39(3):419-428. PubMed ID: 37304482
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of cyclosporin A in the treatment of adult patients with aplastic anemia].
Mikhaĭlova EA; Savchenko VG; Ustinova EN; Kokhno AV; Iadrikhinskaia VN; Tiurina NG; Sokolov AN; Tikhonova LIu; Diagileva OA; Kozinets DI; Maslova ER; Kulikov SM
Ter Arkh; 2001; 73(7):56-61. PubMed ID: 11523411
[TBL] [Abstract][Full Text] [Related]
14. Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
Scheinberg P
Br J Haematol; 2021 Sep; 194(6):954-969. PubMed ID: 33855695
[TBL] [Abstract][Full Text] [Related]
15. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
16. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia.
Gluckman E; Rokicka-Milewska R; Hann I; Nikiforakis E; Tavakoli F; Cohen-Scali S; Bacigalupo A;
Br J Haematol; 2002 Dec; 119(4):1075-82. PubMed ID: 12472591
[TBL] [Abstract][Full Text] [Related]
17. [Bone marrow findings of childhood aplastic anemia: analyses of 140 cases by central reviewers].
Hama A; Yoshimi A; Sakaguchi H; Doisaki S; Muramatsu H; Shimada A; Takahashi Y; Nozawa K; Ito M; Tsuchida M; Manabe A; Ohara A; Kojima S
Rinsho Ketsueki; 2011 Aug; 52(8):653-8. PubMed ID: 21897071
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Scheinberg P; Nunez O; Wu C; Young NS
Br J Haematol; 2006 Jun; 133(6):606-11. PubMed ID: 16704434
[TBL] [Abstract][Full Text] [Related]
19. Relative erythroid hyperplasia in the bone marrow at diagnosis of aplastic anaemia: a predictive marker for a favourable response to cyclosporine therapy.
Nakao S; Yamaguchi M; Takamatsu H; Takami A; Chuhjo T; Ueda M; Shiobara S; Matsuda T
Br J Haematol; 1996 Feb; 92(2):318-23. PubMed ID: 8602992
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going.
Risitano AM
Br J Haematol; 2011 Jan; 152(2):127-40. PubMed ID: 21118194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
